Creation of a drug to prevent premature aging in humans, drug composition and method of compound selection based on use of siRNA from NFKbiz

Developed by: Instituto de Investigación Sanitaria Fundación Jiménez Díaz

Description

Description

 Inhibition of NFKbiz prevents aging by maintaining normal expression of Klotho in patients with systemic inflammation of any cause.

Applications

Use of NFKbiz inhibitors in treatment and prevention of acute kidney damage.

Protection status

Request for national patent submitted to the Spanish Patent and Trademark Office.

Cooperation requested

Search for licensees for the patent

Search for partners to undertake joint development of the technology

Therapy Area

Nephrology

Immunology

Technology Area

Biotechnology and molecular diagnosis

Status:
N/A
Health technology:
N/A